The device was not returned.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot and relabeled lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents reported from this lot and relabeled.The investigation was unable to determine a conclusive cause for the reported stent migration.The reported patient effect of embolism is listed in instructions for use (ifu) as a known patient effect of coronary stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture.
|
It was reported the procedure was performed on (b)(6) 2018, to treat a lesion in the right common iliac artery.The 9.0x39mm omnilink elite stent was implanted without issue.On (b)(6) 2020, a second procedure was performed to treat an aortic aneurysm.It was noted the omnilink elite was not where it had been deployed.The stent was noted in the aortic aneurysm.Another stent was implanted, crushing the omnilink stent against the vessel wall.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.
|